- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04321447
Clinical Practice Guideline for Neonatal Extravasation Injury
March 23, 2020 updated by: CHAN Kam Ming, United Christian Hospital
Clinical Practice Guideline on the Prevention and Management of Neonatal Extravasation Injury
This study is aimed to evaluate the effectiveness of an evidence-based clinical practice guideline in the prevention and management of neonatal extravasation injury, and to examine the change in nurses' knowledge of and adherence to the guideline.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A study with controlled before-and-after design was conducted.
The clinical practice guideline was developed and a multifaceted educational program was delivered for nurses.
Neonatal outcomes were collected at baseline and after completion of the intervention.
The changes in nurses' level of knowledge and adherence to the guideline were also measured.
Study Type
Interventional
Enrollment (Actual)
213
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Neonates who were admitted for intravenous medication or infusion therapy, and
- Neonates whose parents were equal to or over 18 years old and able to communicate in Chinese or English.
Exclusion Criteria:
- Neonates who were born with congenital dermatological problems such as ichthyosis and epidermolysis bullosa.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Clinical practice guideline (CPG) group
Implementation of an evidence-based clinical practice guideline and delivery of an educational programme
|
Implementation of an evidence-based clinical practice guideline and delivery of an educational programme for nurses
|
|
No Intervention: Usual care group
Usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in rate of peripheral intravenous extravasation
Time Frame: Change from Baseline rate at one month
|
The number of the incidents divided by the total number of catheter days and multiplied by 1,000
|
Change from Baseline rate at one month
|
|
Change in rate of extravasation from a central line
Time Frame: Change from Baseline rate at one month
|
The number of the incidents divided by the total number of catheter days and multiplied by 1,000
|
Change from Baseline rate at one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in nurses' level of knowledge
Time Frame: Change from Baseline Knowledge level at six months
|
The Neonatal Extravasation Knowledge Test
|
Change from Baseline Knowledge level at six months
|
|
Change in nurses' adherence to clinical practice guidelines
Time Frame: Change from Baseline Adherence level at six months
|
A 27-item audit tool
|
Change from Baseline Adherence level at six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kam Ming Chan, United Christian Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 14, 2015
Primary Completion (Actual)
November 23, 2016
Study Completion (Actual)
August 29, 2017
Study Registration Dates
First Submitted
March 20, 2020
First Submitted That Met QC Criteria
March 23, 2020
First Posted (Actual)
March 25, 2020
Study Record Updates
Last Update Posted (Actual)
March 25, 2020
Last Update Submitted That Met QC Criteria
March 23, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPGneonatalextravasation
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Extravasation Injury
-
Augusta UniversityCompleted
-
Rawalpindi Medical CollegeCompletedExtravasation Injury | Extravasation | Neonatal Peripheral Intravenous Cannulation | Limb Splinting | Intravenous Cannula LifespanPakistan
-
OnxeoCompletedExtravasationDenmark, Germany, Italy, Netherlands, Poland
-
ivWatch, LLCCompletedExtravasation of Diagnostic and Therapeutic Materials | Extravasation | Infiltration | IV Infiltration | IV ExtravasationUnited States
-
OnxeoCompletedAnthracycline ExtravasationDenmark
-
Roswell Park Cancer InstituteCompletedOncology | ExtravasationUnited States
-
University Hospital, LinkoepingCompletedBlood Volume, ExtravasationSweden
-
Rhaeos, Inc.RecruitingIV Infiltration | IV ExtravasationUnited States
-
Selcuk UniversityNot yet recruitingExtravasation | Infiltration of Peripheral IV TherapyTurkey (Türkiye)
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedExtravasation Injury | Infant, Premature, DiseasesItaly
Clinical Trials on Clinical practice guideline for prevention and management of extravasation injury
-
Ministry of Health, MalaysiaCompleted
-
Boston Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
University Hospital of FerraraCompletedMyocardial Ischemia | Quality of Life | Hemorrhage | Platelet Aggregation InhibitorsItaly
-
Guy's and St Thomas' NHS Foundation TrustRecruiting
-
KRKAUniversity Medical Centre Ljubljana; University of Ljubljana School of Medicine... and other collaboratorsCompletedPeripheral Arterial DiseaseSlovenia
-
Yi YangNot yet recruitingAcute Ischemic StrokeChina
-
Ain Shams UniversityRecruitingMyocardial Infarction | Reperfusion Injury, MyocardialEgypt
-
Medstar Health Research InstituteCompletedType 2 Diabetes MellitusUnited States
-
Oscar Diaz-CambroneroInstituto de Investigacion Sanitaria La Fe; INCLIVACompletedNeuromuscular BlockadeSpain
-
University of PennsylvaniaCompletedDepression | Anxiety | Caregiver Stress SyndromeUnited States